Experience with type I interferon inhibitor in systemic lupus erythematosus

The article describes a clinical case of systemic lupus erythematosus (SLE) resistant to traditional treatment regimens and the first successful experience with the type I interferon inhibitor – anifrolumab, as part of an early access program in the Russian Federation. High efficacy and safety of th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Sovremennai͡a︡ revmatologii͡a 2022-08, Vol.16 (4), p.69-73
Hauptverfasser:	Leineman, Ya. A., Bessalova, A. Yu, Aliev, D. B., Samigullina, R. R., Shostak, M. S., Gaidukova, I. Z., Mazurov, V. I.
Format:	Artikel
Sprache:	eng
Schlagworte:	anifrolumab clinical case discoid lupus erythematosus systemic lupus erythematosus type i interferon inhibitor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The article describes a clinical case of systemic lupus erythematosus (SLE) resistant to traditional treatment regimens and the first successful experience with the type I interferon inhibitor – anifrolumab, as part of an early access program in the Russian Federation. High efficacy and safety of the drug in the treatment of SLE with active lesions of the skin, mucous membranes and joints were noted.
ISSN:	1996-7012 2310-158X
DOI:	10.14412/1996-7012-2022-4-69-73